Scinovex
article Open AccessTop 1% cited

The global burden of cancer: priorities for prevention

Carcinogenesis · 2009 · Vol. 31(1) · pp. 100–110
M. J. ThunJohn O. L. DeLanceyAhmedin JemalElizabeth Ward

Abstract

Despite decreases in the cancer death rates in high-resource countries, such as the USA, the number of cancer cases and deaths is projected to more than double worldwide over the next 20-40 years. Cancer is now the third leading cause of death, with >12 million new cases and 7.6 million cancer deaths estimated to have occurred globally in 2007. By 2030, it is projected that there will be approximately 26 million new cancer cases and 17 million cancer deaths per year. The projected increase will be driven largely by growth and aging of populations and will be largest in low- and medium-resource countries. Under current trends, increased longevity in developing countries will nearly triple the number of people who survive to age 65 by 2050. This demographic shift is compounded by the entrenchment of modifiable risk factors such as smoking and obesity in many low-and medium-resource countries and by the slower decline in cancers related to chronic infections (especially stomach, liver and uterine cervix) in economically developing than in industrialized countries. This paper identifies several preventive measures that offer the most feasible approach to mitigate the anticipated global increase in cancer in countries that can least afford it. Foremost among these are the need to strengthen efforts in international tobacco control and to increase the availability of vaccines against hepatitis B and human papilloma virus in countries where they are most needed.

Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionBRCA gene mutations in cancerMedicineCancerCancer preventionDeveloped countryDeveloping countryEnvironmental healthCervical cancerGlobal healthCause of deathLiver cancer

MeSH terms

FemaleHumansMaleMortalityNeoplasmsRisk Factors
Citations
1,076
FWCI
18.46
field-weighted impact
References
62
Percentile
100%
vs. same field & year
Citations per year
Cited by
The biology and treatment of EML4-ALK non-small cell lung cancer
European Journal of Cancer · 2010 · 556 citations
Exploring Possible Anticancer Potential Of Some Plants Of Cucurbitaceae Family
Journal of Pharmacognosy and Phytochemistry · 2017 · 0 citations
References
Global Cancer Statistics, 2002
CA A Cancer Journal for Clinicians · 2005 · 18,373 citations
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Journal of Clinical Pathology · 1995 · 8,764 citations
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans
Journal of Clinical Pathology · 1980 · 3,467 citations
Global cancer statistics
CA A Cancer Journal for Clinicians · 2011 · 55,006 citations
The global health burden of infection‐associated cancers in the year 2002
International Journal of Cancer · 2006 · 2,920 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The global burden of cancer: priorities for prevention · Scinovex